Brief: Natco Pharma Prices Risdiplam At 15,900 Rupees MRP
08/04/2025 06:37
April 8 (Reuters) - Natco Pharma Ltd NATP.NS: NATCO PHARMA LTD - DELHI HIGH COURT DENIES ROCHE'S INJUNCTION PLEA AGAINST NATCO NATCO PHARMA LTD - UPDATES ON LEGAL PROCEEDINGS FOR RISDIPLAM LAUNCH IN INDIA NATCO PHARMA LTD - ROCHE APPEALS DECISION, APPELLATE BENCH DIRECTS STATUS QUO NATCO PHARMA LTD - PRICES RISDIPLAM AT 15,900 RUPEES MRP NATCO PHARMA LTD - TO OFFER DISCOUNT ON RISDIPLAM THROUGH PATIENT ACCESS PROGRAMME NATCO PHARMA: INTENDS TO LAUNCH RISDIPLAM AFTER CLARITY FROM APPELLATE BENCH, WHICH IS EXPECTED SHORTLY Source text: ID:nBSE1wdNMH Further company coverage: NATP.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees